SII doing best to ramp up COVID-19 vaccine production, says CEO Adar Poonawalla


Serum Institute of India (SII) is doing its best to ramp up the production of COVID-19 vaccine Covishield to cater to demand in the country, Adar Poonawalla said on Saturday. Responding to a tweet by JSW Group Chairman Sajjan Jindal, Poonawalla said the vaccine major is doing its best to introduce vaccines on priority for the Indian market.

“Yes@sajjanjindal, we at @SerumInstIndia are doing our best to ramp up production & launch new vaccines on priority for India. We are grateful for @TheJSWGroup efforts in trying to fulfill India’smedical oxygen needs as we stand together in this fight against this pandemic,” Poonawalla said in a tweet.

Earlier Sajjan Jindal had tweeted while tagging SII, Poonawalla, Bharat Biotech and its Managing Director Krishna Ella: “The only way we can win the #FightAgainstCOVID19in India is to vaccinate everybody. Great to see @SerumInstIndia @adarpoonawalla and@BharatBiotech @krishnaella ramping up their capacities.”
Both SII and Bharat Biotech are at the forefront of supplying COVID-19 vaccines in the country even as the second wave of the pandemic continues to ravage various states.





READ SOURCE

READ  "Bad recession" in 2020: JPMorgan CEO Jamie Dimon

LEAVE A REPLY

Please enter your comment!
Please enter your name here